Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID05958940

BioClock: Optimization, Working Mechanisms and Response Predictors of Bright Light Therapy for Depressive Disorders - a Multicentre Randomized Controlled Trial

Led by Universiteit Leiden · Updated on 2025-01-09

231

Participants Needed

2

Research Sites

13 weeks

Total Duration

On this page

Sponsors

U

Universiteit Leiden

Lead Sponsor

E

Eindhoven University of Technology

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying Bright Light Therapy (BLT) to improve treatment for people experiencing depressive episodes, including unipolar and bipolar depression. The trial aims to optimize how BLT is given, understand how it works in the body, and identify which patients benefit most. It seeks to explore whether lifestyle changes and biological clock adjustments can enhance BLT's effects and develop a brain model to see how BLT influences the brain. Participants receive BLT using a 10,000 lux light lamp for 30 minutes each morning over 5 consecutive days. The treatment lasts between one and three weeks, depending on symptom improvement. Patients are randomly assigned to one of three groups: receiving BLT at home following standard guidelines, receiving BLT in a specialized café that promotes lifestyle and social interaction with fixed daily timing, or receiving BLT in the café with varied timing plus wearing blue light blocking glasses in the evening. Before, during, and after treatment, participants wear devices to monitor sleep, activity, and light exposure. They also complete frequent mood and vitality questionnaires via smartphone. Researchers assess clinical and biological factors that may predict treatment response, including brain scans for functional and structural changes. The study includes a baseline phase up to two weeks, a treatment phase up to three weeks, and a three-month follow-up to evaluate clinical improvement and other outcomes.

CONDITIONS

Brief Title

BioClock: Bright Light Therapy for Depressive Disorders

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 65 years
  • Diagnosis of unipolar or bipolar depression (seasonal or non-seasonal) confirmed by Mini-International Neuropsychiatric Interview (M.I.N.I.)
  • Currently experiencing a depressive episode with a score of 6 or higher on the Quick Inventory of Depressive Symptomatology Self Report (QIDS-SR)
  • Sufficient knowledge of Dutch or English to complete questionnaires
  • Provided informed consent
Not Eligible

You will not qualify if you...

  • Currently experiencing a manic, hypomanic, or mixed episode assessed by M.I.N.I.
  • Current psychotic episode assessed by M.I.N.I.
  • Active suicidality with a score of 10 or higher on the M.I.N.I. module
  • Started antidepressant therapy, psychotherapy, BLT, or other specific depression treatments less than 2 months prior
  • Bipolar disorder patients not on mood-stabilizing treatment for at least 1 month in recommended dosage
  • Use of melatonin or agomelatine in the past month
  • Current use of antibiotics
  • Current use of medication that increases light sensitivity
  • Travel across more than one time zone in past month or during treatment
  • Travel to sunny holiday locations or winter sports in past month
  • Pre-existing eye or skin disorders such as retinitis pigmentosa, porphyria, chronic actinic dermatitis, or sun-induced urticaria
  • Systemic disorders potentially affecting the retina (rheumatoid arthritis, systemic lupus erythematosus)
  • Color blindness as assessed by Ishihara color plates
  • Night shift work in the last three months
  • Retinal blindness, severe cataract, or glaucoma
  • History of light-induced migraine or epilepsy
  • Pregnancy or having a child younger than 18 months old

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 1 to 3 weeks

Participants receive Bright Light Therapy sessions Monday to Friday mornings for one work week. If depressive symptoms do not sufficiently improve, additional treatment sessions may be added in one to three weekly extensions. Some participants also wear blue light blocking glasses in the evening and follow personalized therapy timing based on their sleep-wake patterns.

5 to 15 sessions over 1 to 3 weeks (in-person or supervised depending on group assignment)

Follow-up

Duration - Up to 4 months

Participants are monitored for changes in depressive symptoms, sleep quality, and circadian rhythms up to approximately 4 months after starting treatment.

Periodic assessments during follow-up period

Trial Site Locations

Total: 2 locations

1

GGzE - Mental Health Institute of Eindhoven and the Kempen

Eindhoven, Netherlands, 5626 ND

Actively Recruiting

2

Leids Universitair Behandel- en Expertise Centrum

Leiden, Netherlands, 5626 ND

Actively Recruiting

Loading map...

Research Team

N

Niki Antypa, PhD

L

Luc Schlangen, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

A Multicenter, Randomized, Double Blind, Placebo-controlled ...

Depression, Bipolar

Actively Recruiting

1 location

Acceptability & Safety of Two Sequential Doses of Psilocybin...

Bipolar II Disorder

Actively Recruiting

1 location

Bright Light Therapy for Adolescents With Depression and Eve...

Depression, Unipolar

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

BioClock-optimizing Bright Light Therapy for adults with depression: a study protocol for a multicenter randomized clinical trial on treatment strategies, response predictors, and chronobiological and neurobiological mechanisms.

E Visser, O G Rus-Oswald, A J W van der Does...

https://pubmed.ncbi.nlm.nih.gov/41088238